Halbert Hargrove Global Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$266K	Hold	1,000	–	–	0.01%	90
2026 Q2	$292K	Hold	1,000	–	–	0.01%	87
2026 Q1	$166K	Buy	+1,000	New	+$164K	0.01%	106

Other funds holding LABU

Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return

Halbert Hargrove Global Advisors's LABU Position: Q3 2026 in Review

Halbert Hargrove Global Advisors held its Direxion Daily S&P Biotech Bull 3X ETF (LABU) position steady in Q3 2026 at 1,000 shares worth $266K. The position accounts for 0.01% of the portfolio, ranked #90.

Halbert Hargrove Global Advisors first reported a position in LABU in Q1 2026 and has held it in 3 quarters since. The position peaked at $292K in Q2 2026. 2 funds tracked by Wall St. Rank hold LABU as of Q3 2026.

Halbert Hargrove Global Advisors held 1,000 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $266K as of Q3 2026.
Halbert Hargrove Global Advisors left its Direxion Daily S&P Biotech Bull 3X ETF share count unchanged in Q3 2026.
Direxion Daily S&P Biotech Bull 3X ETF made up 0.01% of Halbert Hargrove Global Advisors's portfolio in Q3 2026, its #90 holding.
Halbert Hargrove Global Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2026 and has held it in 3 quarters since.
Halbert Hargrove Global Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $292K in Q2 2026.
2 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.